Cortesina G, Cavallo G P, Beatrice F, Sartoris A, Bussi M, Morra B, Di Fortunato V, Poggio E, Rendine S
Tumori. 1982 Feb 28;68(1):39-46. doi: 10.1177/030089168206800107.
The production of leukocyte migration inhibition factor (LIF) from lymphocytes after stimulation with 3 M KCl soluble tumor and normal mucosa extracts was investigated in 30 patients with laryngeal carcinoma at different development stages and in 30 normal donors. The experiments were performed in heterologous and autologous systems. In heterologous systems 3 M KCl tumor extracts induced LIF production by heterologous lymphocytes from patients in 91% of the cases, and normal mucosa extracts induced LIF production by heterologous lymphocytes from patients in 73% of the cases and from normal donors in 90% of the cases. In autologous systems 3 M KCl tumor extracts induced LIF production by autologous lymphocytes from the same patients in 65% of the cases, whereas the normal laryngeal mucosa extracts induced LIF production by the same autologous lymphocytes in the 6% of the cases. The high positivity percentage of the test in heterologous systems could be related to differences in the major histocompatibility complex. The 65% test positivity in autologous systems using tumor extracts could be related to the presence of tumor associated antigens.
在30例处于不同发展阶段的喉癌患者和30名正常供体中,研究了用3M KCl可溶性肿瘤提取物和正常黏膜提取物刺激淋巴细胞后白细胞迁移抑制因子(LIF)的产生情况。实验在异源和自体系统中进行。在异源系统中,3M KCl肿瘤提取物在91%的病例中诱导患者异源淋巴细胞产生LIF,正常黏膜提取物在73%的病例中诱导患者异源淋巴细胞产生LIF,在90%的病例中诱导正常供体异源淋巴细胞产生LIF。在自体系统中,3M KCl肿瘤提取物在65%的病例中诱导同一患者的自体淋巴细胞产生LIF,而正常喉黏膜提取物在6%的病例中诱导同一自体淋巴细胞产生LIF。异源系统中检测的高阳性率可能与主要组织相容性复合体的差异有关。使用肿瘤提取物的自体系统中65%的检测阳性率可能与肿瘤相关抗原的存在有关。